BridgeMD
New treatment option for Temporomandibular Disorders (TMDs)
Official title Peloid Therapy in Temporomandibular Joint Dysfunction
ClinicalTrials.gov ID: NCT07576582
What this study is testing
- What it's testing
- This prospective, single-group clinical study will evaluate whether local peloid therapy improves pain and jaw function in adults with temporomandibular joint dysfunction. Participants will receive peloid therapy applied to the temporomandibular joint region and masticatory muscles for 20 minutes per session, 5 days per week, for 2 weeks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age between 18 and 65 years
- Diagnosis of temporomandibular joint dysfunction based on DC/TMD criteria
- Presence of TMJ-related pain for at least 4 weeks
- Baseline pain intensity ≥3 on a 0-10 visual analog scale
- Ability to provide written informed consent
You likely can't join if
- History of temporomandibular joint trauma, tumor, active infection, or acute inflammation
- Previous temporomandibular joint surgery
- Presence of systemic inflammatory rheumatologic disease
- Pregnancy
- Open wound, active dermatitis, or skin condition preventing peloid application at the treatment site
- Injection therapy (e.g., botulinum toxin) or regular physical therapy for TMJ within the past 3 months
See the full eligibility criteria
- Age between 18 and 65 years
- Diagnosis of temporomandibular joint dysfunction based on DC/TMD criteria
- Presence of TMJ-related pain for at least 4 weeks
- Baseline pain intensity ≥3 on a 0-10 visual analog scale
- Ability to provide written informed consent
- History of temporomandibular joint trauma, tumor, active infection, or acute inflammation
- Previous temporomandibular joint surgery
- Presence of systemic inflammatory rheumatologic disease
- Pregnancy
- Open wound, active dermatitis, or skin condition preventing peloid application at the treatment site
- Injection therapy (e.g., botulinum toxin) or regular physical therapy for TMJ within the past 3 months
- Any clinical or behavioral condition that may interfere with study compliance
The study team makes the final eligibility decision.
Where it's taking place
- Uşak, Merkez, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Uşak, Merkez, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.